Dong H, Mahmud T, Tornus I, Lee S, Floss H G
Department of Chemistry, Box 351700, University of Washington, Seattle, WA 98195-1700, USA.
J Am Chem Soc. 2001 Mar 28;123(12):2733-42. doi: 10.1021/ja003643n.
To study the biosynthesis of the pseudotrisaccharide antibiotic, validamycin A (1), a number of potential precursors of the antibiotic were synthesized in (2)H-, (3)H-, or (13)C-labeled form and fed to cultures of Streptomyces hygroscopicus var. limoneus. The resulting validamycin A from each of these feeding experiments was isolated, purified and analyzed by liquid scintillation counting, (2)H- or (13)C NMR or selective ion monitoring mass spectrometry (SIM-MS) techniques. The results demonstrate that 2-epi-5-epi-valiolone (9) is specifically incorporated into 1 and labels both cyclitol moieties. This suggests that 9 is the initial cyclization product generated from an open-chain C(7) precursor, D-sedoheptulose 7-phosphate (5), by a DHQ synthase-like cyclization mechanism. A more proximate precursor of 1 is valienone (11), which is also incorporated into both cyclitol moieties. The conversion of 9 into 11 involves first epimerization to 5-epi-valiolone (10), which is efficiently incorporated into 1, followed by dehydration, although a low level of incorporation of 2-epi-valienone (15) is also observed. Reduction of 11 affords validone (12), which is also incorporated specifically into 1, but labels only the reduced cyclitol moiety. The mode of introduction of the nitrogen atom linking the two pseudosaccharide moieties is not clear yet. 7-Tritiated valiolamine (8), valienamine (2), and validamine (3) were all not incorporated into 1, although each of these amines has been isolated from the fermentation, with 3 being most prevalent. Demonstration of in vivo formation of [7-(3)H]validamine ([7-(3)H]-3) from [7-(3)H]-12 suggests that 3 may be a pathway intermediate and that the nonincorporation of [7-(3)H]-3 into 1 is due to a lack of cellular uptake. We thus propose that 3, formed by amination of 12, and 11 condense to form a Schiff base, which is reduced to the pseudodisaccharide unit, validoxylamine A (13). Transfer of a D-glucose unit to the 4'-position of 13 then completes the biosynthesis of 1. Other possibilities for the mechanism of formation of the nitrogen bridge between the two pseudosaccharide units are also discussed.
为了研究假三糖抗生素井冈霉素A(1)的生物合成,合成了多种(2)H-、(3)H-或(13)C标记形式的该抗生素潜在前体,并将其加入到吸水链霉菌柠檬变种的培养物中。从这些饲喂实验得到的井冈霉素A被分离、纯化,并通过液体闪烁计数、(2)H-或(13)C核磁共振或选择性离子监测质谱(SIM-MS)技术进行分析。结果表明,2-表-5-表-缬草酮(9)被特异性地掺入到1中,并标记了两个环醇部分。这表明9是由开链C(7)前体D-景天庚酮糖7-磷酸(5)通过类似DHQ合酶的环化机制产生的初始环化产物。1的更直接前体是井冈酮(11),它也被掺入到两个环醇部分。9转化为11首先涉及差向异构化为5-表-缬草酮(10),其能有效地掺入到1中,随后脱水,不过也观察到2-表-井冈酮(15)有少量掺入。11的还原得到井冈醇(12),它也被特异性地掺入到1中,但只标记了还原的环醇部分。连接两个假糖部分的氮原子的引入方式尚不清楚。7-氚代缬氨醇(8)、井冈胺(2)和有效胺(3)均未掺入到1中,尽管这些胺都已从发酵产物中分离出来,其中3最为常见。[7-(3)H]有效胺([7-(3)H]-3)由[7-(3)H]-12在体内形成的结果表明,3可能是一条途径的中间体,[7-(3)H]-3未掺入到1中是由于缺乏细胞摄取。因此我们提出,由12胺化形成的3与11缩合形成席夫碱,然后还原为假二糖单元井冈霉胺A(13)。将一个D-葡萄糖单元转移到13的4'-位然后完成了1的生物合成。还讨论了两个假糖单元之间氮桥形成机制的其他可能性。